GenSight Biologics S.A. announced a private placement of common shares at a price of ?0.025 for the gross proceeds of ?1,546,199.455 on May 7, 2024.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.363 EUR | -0.82% | -6.80% | -21.09% |
May. 07 | GenSight Biologics S.A. announced that it expects to receive ?1.546199 million in funding | CI |
Apr. 05 | GenSight: financial visibility assured until the end of April | CF |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-21.09% | 39.97M | |
+11.91% | 118B | |
+11.60% | 106B | |
-4.68% | 24.28B | |
-0.82% | 21.96B | |
-10.12% | 18.16B | |
-42.12% | 16.37B | |
-17.47% | 15.56B | |
+2.77% | 13.63B | |
+34.58% | 12.27B |
- Stock Market
- Equities
- SIGHT Stock
- News GenSight Biologics S.A.
- GenSight Biologics S.A. announced that it expects to receive ?1.546199 million in funding